1. Home
  2. Pharma & Healthcare
  3. Global Cell and Gene Therapy CDMO Market Status and Forecast 2021-2027

Global Cell and Gene Therapy CDMO Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 131 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Cell and Gene Therapy CDMO market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Cell and Gene Therapy CDMO industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Cell and Gene Therapy CDMO market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Cell and Gene Therapy CDMO Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy CDMO market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Cell and Gene Therapy CDMO Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Cell and Gene Therapy CDMO industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA

Segmented by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
WuXi AppTec
Thermo Fisher
Rentschler Biopharma
Porton
Pharmaron
Oxford Biomedica (OXB)
OBiO
Novartis
Lonza
GenScript
Catalent
Asymchem


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Cell and Gene Therapy CDMO Market Status and Forecast (2016-2027)
1.3.2 Global Cell and Gene Therapy CDMO Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Cell and Gene Therapy CDMO Supply by Company
2.1 Global Cell and Gene Therapy CDMO Sales Value by Company
2.2 Cell and Gene Therapy CDMO Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Cell and Gene Therapy CDMO Market Status by Type
3.1 Cell and Gene Therapy CDMO Type Introduction
3.1.1 Immune Cells
3.1.2 Stem Cells
3.1.3 Viral Vectors
3.1.4 Plasmid DNA
3.2 Global Cell and Gene Therapy CDMO Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Cell and Gene Therapy CDMO Market Status by Application
4.1 Cell and Gene Therapy CDMO Segment by Application
4.1.1 Pharmaceutical and Biotechnology Companies
4.1.2 Research and Academic Institutions
4.1.3 Hospital
4.1.4 Others
4.2 Global Cell and Gene Therapy CDMO Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Cell and Gene Therapy CDMO Market Status by Region
5.1 Global Cell and Gene Therapy CDMO Market by Region
5.2 North America Cell and Gene Therapy CDMO Market Status
5.3 Europe Cell and Gene Therapy CDMO Market Status
5.4 Asia Pacific Cell and Gene Therapy CDMO Market Status
5.5 Central & South America Cell and Gene Therapy CDMO Market Status
5.6 Middle East & Africa Cell and Gene Therapy CDMO Market Status
6 North America Cell and Gene Therapy CDMO Market Status
6.1 North America Cell and Gene Therapy CDMO Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Cell and Gene Therapy CDMO Market Status
7.1 Europe Cell and Gene Therapy CDMO Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Cell and Gene Therapy CDMO Market Status
8.1 Asia Pacific Cell and Gene Therapy CDMO Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Cell and Gene Therapy CDMO Market Status
9.1 Central & South America Cell and Gene Therapy CDMO Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Cell and Gene Therapy CDMO Market Status
10.1 Middle East & Africa Cell and Gene Therapy CDMO Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Cell and Gene Therapy CDMO Market Forecast by Type and by Application
12.1 Global Cell and Gene Therapy CDMO Sales Value Forecast (2022-2027)
12.2 Global Cell and Gene Therapy CDMO Forecast by Type
12.3 Global Cell and Gene Therapy CDMO Forecast by Application
13 Global Cell and Gene Therapy CDMO Market Forecast by Region/Country
13.1 Global Cell and Gene Therapy CDMO Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 WuXi AppTec
14.1.1 Company Information
14.1.2 Cell and Gene Therapy CDMO Product Introduction
14.1.3 WuXi AppTec Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Thermo Fisher
14.2.1 Company Information
14.2.2 Cell and Gene Therapy CDMO Product Introduction
14.2.3 Thermo Fisher Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Rentschler Biopharma
14.3.1 Company Information
14.3.2 Cell and Gene Therapy CDMO Product Introduction
14.3.3 Rentschler Biopharma Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Porton
14.4.1 Company Information
14.4.2 Cell and Gene Therapy CDMO Product Introduction
14.4.3 Porton Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Pharmaron
14.5.1 Company Information
14.5.2 Cell and Gene Therapy CDMO Product Introduction
14.5.3 Pharmaron Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Oxford Biomedica (OXB)
14.6.1 Company Information
14.6.2 Cell and Gene Therapy CDMO Product Introduction
14.6.3 Oxford Biomedica (OXB) Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 OBiO
14.7.1 Company Information
14.7.2 Cell and Gene Therapy CDMO Product Introduction
14.7.3 OBiO Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Novartis
14.8.1 Company Information
14.8.2 Cell and Gene Therapy CDMO Product Introduction
14.8.3 Novartis Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Lonza
14.9.1 Company Information
14.9.2 Cell and Gene Therapy CDMO Product Introduction
14.9.3 Lonza Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 GenScript
14.10.1 Company Information
14.10.2 Cell and Gene Therapy CDMO Product Introduction
14.10.3 GenScript Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Catalent
14.12 Asymchem
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Cell and Gene Therapy CDMO Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Cell and Gene Therapy CDMO Sales Value (Million USD) by Company (2019-2021)
Table Global Cell and Gene Therapy CDMO Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Cell and Gene Therapy CDMO Sales Area
Table Cell and Gene Therapy CDMO Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Cell and Gene Therapy CDMO Sales Value (Million USD) by Type (2016-2021)
Table Global Cell and Gene Therapy CDMO Sals Value Market Share by Type (2016-2021)
Table North America Cell and Gene Therapy CDMO Sales Value (Million USD) by Type (2016-2021)
Table North America Cell and Gene Therapy CDMO Sales Value Market Share by Type (2016-2021)
Table Europe Cell and Gene Therapy CDMO Sales Value (Million USD) by Type (2016-2021)
Table Europe Cell and Gene Therapy CDMO Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Cell and Gene Therapy CDMO Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Cell and Gene Therapy CDMO Sales Value Market Share by Type (2016-2021)
Table Central & South America Cell and Gene Therapy CDMO Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Cell and Gene Therapy CDMO Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Cell and Gene Therapy CDMO Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Cell and Gene Therapy CDMO Sales Value Market Share by Type (2016-2021)
Table Global Cell and Gene Therapy CDMO Sales Value (Million USD) by Application (2016-2021)
Table Global Cell and Gene Therapy CDMO Value Market Share by Application (2016-2021)
Table North America Cell and Gene Therapy CDMO Sales Value (Million USD) by Application (2016-2021)
Table North America Cell and Gene Therapy CDMO Sales Value Market Share by Application (2016-2021)
Table Europe Cell and Gene Therapy CDMO Sales Value (Million USD) by Application (2016-2021)
Table Europe Cell and Gene Therapy CDMO Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Cell and Gene Therapy CDMO Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Cell and Gene Therapy CDMO Sales Value Market Share by Application (2016-2021)
Table Central & South America Cell and Gene Therapy CDMO Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Cell and Gene Therapy CDMO Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Cell and Gene Therapy CDMO Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Cell and Gene Therapy CDMO Sales Value Market Share by Application (2016-2021)
Table Global Cell and Gene Therapy CDMO Sales Value (Million USD) by Region (2016-2021)
Table Global Cell and Gene Therapy CDMO Value Market Share by Region (2016-2021)
Table North America Cell and Gene Therapy CDMO Sales Value (Million USD) by Country (2016-2021)
Table North America Cell and Gene Therapy CDMO Value Market Share by Country (2016-2021)
Table Europe Cell and Gene Therapy CDMO Sales Value (Million USD) by Country (2016-2021)
Table Europe Cell and Gene Therapy CDMO Value Market Share by Country (2016-2021)
Table Asia Pacific Cell and Gene Therapy CDMO Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Cell and Gene Therapy CDMO Value Market Share by Country (2016-2021)
Table Central & South America Cell and Gene Therapy CDMO Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Cell and Gene Therapy CDMO Value Market Share by Country (2016-2021)
Table Middle East & Africa Cell and Gene Therapy CDMO Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Cell and Gene Therapy CDMO Value Market Share by Country (2016-2021)
Table Global Cell and Gene Therapy CDMO Value (Million USD) Forecast by Type (2022-2027)
Table Global Cell and Gene Therapy CDMO Value Market Share Forecast by Type (2022-2027)
Table Global Cell and Gene Therapy CDMO Value (Million USD) Forecast by Application (2022-2027)
Table Global Cell and Gene Therapy CDMO Value Market Share Forecast by Application (2022-2027)
Table Global Cell and Gene Therapy CDMO Value (Million USD) Forecast by Region (2022-2027)
Table Global Cell and Gene Therapy CDMO Value Market Share Forecast by Region (2022-2027)
Table WuXi AppTec Company Information
Table WuXi AppTec Product Introduction
Table WuXi AppTec Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Thermo Fisher Company Information
Table Thermo Fisher Product Introduction
Table Thermo Fisher Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Rentschler Biopharma Company Information
Table Rentschler Biopharma Product Introduction
Table Rentschler Biopharma Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Porton Company Information
Table Porton Product Introduction
Table Porton Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Pharmaron Company Information
Table Pharmaron Product Introduction
Table Pharmaron Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Oxford Biomedica (OXB) Company Information
Table Oxford Biomedica (OXB) Product Introduction
Table Oxford Biomedica (OXB) Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table OBiO Company Information
Table OBiO Product Introduction
Table OBiO Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table Lonza Company Information
Table Lonza Product Introduction
Table Lonza Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)
Table GenScript Company Information
Table GenScript Product Introduction
Table GenScript Cell and Gene Therapy CDMO Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets